Harnessing Artificial Intelligence for the detection and management of Colorectal Cancer Treatment.

Currently, eight million people in the United States suffer from cancer, and is a major global health concern. Early detection and interventions are urgently needed for all cancers, including colorectal cancer (CRC). CRC is the third most common type of cancer worldwide; From diagnostic efforts to general awareness and lifestyle choices, it is understandable why CRC is so prevalent today. There is a notable lack of awareness concerning the impact of this cancer and its connection to lifestyle elements, as well as people sometimes mistaking symptoms for a different gastrointestinal condition. Artificial Intelligence (AI) may assist in the early detection of all cancers, including CRC. The usage of AI has exponentially grown within healthcare through extensive research and since clinical implementation, has succeeded in improving patient lifestyles, modernizing diagnostic processes, and innovating current treatment strategies. Numerous challenges arise for CRC patients and Oncologists alike during treatment. For initial screening phases, conventional methods oftentimes result in misdiagnosis. Moreover, after detection, determining the course of which CRC can sometimes contribute to treatment delays. This article touches on recent advancements in AI and its clinical application while shedding light on why this disease is so common today.